Free Trial

Tevogen Bio (TVGN) News Today

Tevogen Bio logo
$1.00 -0.07 (-6.54%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.00 +0.00 (+0.50%)
As of 09:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Tevogen Bio Holdings Inc. stock logo
Tevogen Bio (NASDAQ:TVGN) Shares Up 0.9% - Still a Buy?
Tevogen Bio (NASDAQ:TVGN) Trading 0.9% Higher - Time to Buy?
Tevogen Bio appoints new head of government affairs
Tevogen Bio Holdings Inc. stock logo
Neal Flomenberg Sells 232,968 Shares of Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Stock
Tevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) insider Neal Flomenberg sold 232,968 shares of the firm's stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $1.09, for a total value of $253,935.12. Following the completion of the transaction, the insider now owns 3,595,608 shares of the company's stock, valued at $3,919,212.72. This trade represents a 6.08 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Tevogen Bio Holdings Inc. stock logo
Neal Flomenberg Sells 70,384 Shares of Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Stock
Tevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) insider Neal Flomenberg sold 70,384 shares of the business's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $1.09, for a total transaction of $76,718.56. Following the completion of the sale, the insider now owns 3,898,828 shares of the company's stock, valued at $4,249,722.52. The trade was a 1.77 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Tevogen Bio Holdings Inc. stock logo
Tevogen Bio's (TVGN) "Buy" Rating Reaffirmed at D. Boral Capital
D. Boral Capital reissued a "buy" rating and issued a $10.00 price objective on shares of Tevogen Bio in a research note on Tuesday.
Tevogen announces new patent filed for T cell vaccine
Tevogen Bio Holdings Inc. stock logo
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Insider Sells $18,737.92 in Stock
Tevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) insider Neal Flomenberg sold 14,639 shares of the company's stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $1.28, for a total transaction of $18,737.92. Following the completion of the sale, the insider now directly owns 4,239,663 shares in the company, valued at approximately $5,426,768.64. The trade was a 0.34 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.
Tevogen Bio Holdings Inc. stock logo
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Insider Sells $97,370.90 in Stock
Tevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) insider Neal Flomenberg sold 88,519 shares of the business's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $1.10, for a total value of $97,370.90. Following the completion of the sale, the insider now directly owns 4,040,485 shares of the company's stock, valued at $4,444,533.50. The trade was a 2.14 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
Tevogen initiated with a Buy at D. Boral Capital
Tevogen Bio Holdings Inc. stock logo
D. Boral Capital Initiates Coverage on Tevogen Bio (NASDAQ:TVGN)
D. Boral Capital began coverage on shares of Tevogen Bio in a report on Tuesday. They issued a "buy" rating and a $10.00 price objective on the stock.
Tevogen Bio Holdings Inc. stock logo
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Short Interest Down 47.5% in February
Tevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) saw a large decline in short interest in February. As of February 15th, there was short interest totalling 1,460,000 shares, a decline of 47.5% from the January 31st total of 2,780,000 shares. Currently, 5.9% of the shares of the stock are short sold. Based on an average daily trading volume, of 2,750,000 shares, the short-interest ratio is currently 0.5 days.
Tevogen CEO addresses broader implications of short-selling
Tevogen Bio Holdings Inc. stock logo
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Short Interest Update
Tevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 2,780,000 shares, an increase of 127.9% from the January 15th total of 1,220,000 shares. Based on an average daily trading volume, of 3,280,000 shares, the days-to-cover ratio is currently 0.8 days. Approximately 11.2% of the shares of the stock are short sold.
Tevogen Bio Holdings Inc. stock logo
Tevogen Bio (NASDAQ:TVGN) Shares Down 8.9% - Time to Sell?
Tevogen Bio (NASDAQ:TVGN) Trading Down 8.9% - Time to Sell?
Tevogen receives initial $2M grant, may receive $8M more at future date
Remove Ads
Get Tevogen Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter.

TVGN Media Mentions By Week

TVGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TVGN
News Sentiment

0.75

0.61

Average
Medical
News Sentiment

TVGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TVGN Articles
This Week

1

3

TVGN Articles
Average Week

Remove Ads
Get Tevogen Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TVGN) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners